Cargando…

The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy

Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive procedure used for lung cancer diagnosis and staging. Several aspects, including pathological analysis, may impact on its diagnostic accuracy. Differences in diagnostic accuracy between the different specim...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandiera, Alessandro, Arrigoni, Gianluigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794421/
https://www.ncbi.nlm.nih.gov/pubmed/35118287
http://dx.doi.org/10.21037/med-20-28
_version_ 1784640822799499264
author Bandiera, Alessandro
Arrigoni, Gianluigi
author_facet Bandiera, Alessandro
Arrigoni, Gianluigi
author_sort Bandiera, Alessandro
collection PubMed
description Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive procedure used for lung cancer diagnosis and staging. Several aspects, including pathological analysis, may impact on its diagnostic accuracy. Differences in diagnostic accuracy between the different specimen processing techniques have not been demonstrated. Cytological slides are generally adequate for diagnosis, subtyping and genotyping. However, some pathological laboratories may require cell blocks or histological core biopsies for a complete molecular profiling. Rapid on-site evaluation (ROSE) is a technique for immediate evaluation of samples obtained with EBUS-TBNA. The aims of ROSE are to increase sampling adequacy, improving diagnostic yield of EBUS-TBNA and ensuring collection of adequate material for ancillary studies. However, the reported data on the impact of ROSE in the diagnostic yield of EBUS-TBNA and in lung cancer diagnosis and staging are controversial. Some series reported a valuable contribution of ROSE to diagnosis and staging of lung cancer and a high concordance between ROSE and the final diagnosis. However, randomized trials failed in finding differences in diagnostic yield between EBUS-TBNA performed with and without ROSE. The yield of EBUS-TBNA for molecular analyses varies between 72% and 98%, and ROSE may warrant the collection of adequate material for molecular profiling. In lung cancer diagnosis and staging a recommended number of three to four passes during EBUS-TBNA at each target is a minimum requirement to obtain enough material for molecular analysis. The use of ROSE may reduce the number of passes for molecular profiling and the number of additional invasive diagnostic procedures. EBUS-TBNA is a procedure with a high accuracy rate and ROSE may contribute to a further improvement of the results. The possibility to avoid additional invasive procedure is an important advantage leading to an overall improvement of patient care.
format Online
Article
Text
id pubmed-8794421
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-87944212022-02-02 The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy Bandiera, Alessandro Arrigoni, Gianluigi Mediastinum Review Article Endobronchial ultrasound transbronchial needle aspiration (EBUS-TBNA) is a minimally invasive procedure used for lung cancer diagnosis and staging. Several aspects, including pathological analysis, may impact on its diagnostic accuracy. Differences in diagnostic accuracy between the different specimen processing techniques have not been demonstrated. Cytological slides are generally adequate for diagnosis, subtyping and genotyping. However, some pathological laboratories may require cell blocks or histological core biopsies for a complete molecular profiling. Rapid on-site evaluation (ROSE) is a technique for immediate evaluation of samples obtained with EBUS-TBNA. The aims of ROSE are to increase sampling adequacy, improving diagnostic yield of EBUS-TBNA and ensuring collection of adequate material for ancillary studies. However, the reported data on the impact of ROSE in the diagnostic yield of EBUS-TBNA and in lung cancer diagnosis and staging are controversial. Some series reported a valuable contribution of ROSE to diagnosis and staging of lung cancer and a high concordance between ROSE and the final diagnosis. However, randomized trials failed in finding differences in diagnostic yield between EBUS-TBNA performed with and without ROSE. The yield of EBUS-TBNA for molecular analyses varies between 72% and 98%, and ROSE may warrant the collection of adequate material for molecular profiling. In lung cancer diagnosis and staging a recommended number of three to four passes during EBUS-TBNA at each target is a minimum requirement to obtain enough material for molecular analysis. The use of ROSE may reduce the number of passes for molecular profiling and the number of additional invasive diagnostic procedures. EBUS-TBNA is a procedure with a high accuracy rate and ROSE may contribute to a further improvement of the results. The possibility to avoid additional invasive procedure is an important advantage leading to an overall improvement of patient care. AME Publishing Company 2020-09-30 /pmc/articles/PMC8794421/ /pubmed/35118287 http://dx.doi.org/10.21037/med-20-28 Text en 2020 Mediastinum. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0/.
spellingShingle Review Article
Bandiera, Alessandro
Arrigoni, Gianluigi
The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy
title The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy
title_full The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy
title_fullStr The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy
title_full_unstemmed The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy
title_short The impact of pathological analysis on endobronchial ultrasound diagnostic accuracy
title_sort impact of pathological analysis on endobronchial ultrasound diagnostic accuracy
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794421/
https://www.ncbi.nlm.nih.gov/pubmed/35118287
http://dx.doi.org/10.21037/med-20-28
work_keys_str_mv AT bandieraalessandro theimpactofpathologicalanalysisonendobronchialultrasounddiagnosticaccuracy
AT arrigonigianluigi theimpactofpathologicalanalysisonendobronchialultrasounddiagnosticaccuracy
AT bandieraalessandro impactofpathologicalanalysisonendobronchialultrasounddiagnosticaccuracy
AT arrigonigianluigi impactofpathologicalanalysisonendobronchialultrasounddiagnosticaccuracy